URL details: www.camzyoshcp.com/content/commercial/us/camzyoshcp/en/efficacy/secondary-endpoints.html#nyha-class-2
URL title:
CAMZYOS™ (mavacamten) Secondary and Exploratory Endpoints | Safety Profile
URL description:
Explore secondary endpoints of CAMZYOS™ in the EXPLORER-HCM trial. See full Prescribing Info for BOXED WARNING and REMS.
URL last crawled:
2022-09-14
URL speed:
0.459 MB/s,
downloaded in 0.300 seconds
We found no external links pointing to this url.